Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.

British journal of clinical pharmacology - 1 Jul 2012

Mason R Preston, Jacob Robert F, Kubant Ruslan, Jacoby Adam, Louka Febee, Corbalan J Jose, Malinski Tadeusz

Abstract excerpt

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: • Angiotensin II receptor blockers improve endothelial cell-dependent vasodilation in patients with hypertension through suppression of angiotensin II type 1 receptors but may have additional and differential effects on endothelial nitric oxide synthase (eNOS) function. WHAT THIS STUDY ADDS: • The key finding from this study is that angiotensin II receptor blockers (ARBs)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin II Type 1 Receptor Blockers
Share to Benzimidazoles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzoates

Share to Human Umbilical Vein Endothelial Cells

Share to Losartan

Share to Tetrazoles

Share to Umbilical Veins

Share to Vasodilation

Source

Open in PubMed Open full text

Identifiers

PMID: 22283728
DOI: 10.1111/j.1365-2125.2012.04189.x
PMCID: PMC3394138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants.PMID 22283728Read ↗

Endothelial nitric oxide synthase gene: prospects for treatment of heart disease.Semantic proximity Read ↗

Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response.Semantic proximity Read ↗

Nitric oxide and the cardiovascular system: cell activation, vascular reactivity and genetic variant.Semantic proximity Read ↗

The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients.Semantic proximity Read ↗

Influence of endothelial nitric oxide synthase haplotypes on nitric oxide and peroxynitrite productions.Semantic proximity Read ↗

Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide.Semantic proximity Read ↗

Relationship between the G894T polymorphism (Glu298Asp variant) in endothelial nitric oxide synthase and nitric oxide-mediated endothelial function in human atherosclerosis.Semantic proximity Read ↗

Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function.Semantic proximity Read ↗

Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase.Semantic proximity Read ↗

Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease.Semantic proximity Read ↗

eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril.Semantic proximity Read ↗

Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.